Novavax Inc

NASDAQ: NVAX
$8.53
+$0.49 (+6.0%)
Real Time Data Delayed 15 Min.

NVAX Articles

Judging by the most shorted stocks traded on the Nasdaq between the December 29 and January 12 settlement dates, short sellers mostly were loading up on their favorites.
Judging by the most shorted stocks traded on the Nasdaq between the December 15 and December 29 settlement dates, short sellers mostly were willing to yield at year’s end.
The include Axalta, Baidu, Cypress Semi, Merck, Microsoft, Switch top analyst upgrades, downgrades and other research calls from Tuesday.
Judging by most shorted stocks traded on the Nasdaq between the September 29 and October 13 settlement dates, short sellers were growing selective.
Judging by most shorted stocks traded on the Nasdaq between the September 15 and September 29 settlement dates, short sellers overall were cautious.
September can be a volatile time for the markets, and judging by most shorted stocks traded on the Nasdaq, short sellers have had mixed expectations.
As summer began to wind to a close, short selling perked up, at least among the most shorted stocks traded on the Nasdaq.
Short sellers shied away from the two most shorted stocks traded on the Nasdaq between the latest settlement dates, but they moved on other short seller favorites.
The moves in the six most shorted stocks traded on the Nasdaq between July 14 and July 31 suggest that short sellers still were not sure on what to make of major indexes remaining near all-time highs.
Judging by the moves in the six most shorted stocks traded on the Nasdaq between June 30 and July 14, short sellers overall were uncertain what to make of major indexes still near all-time highs.
The most shorted stock traded on the Nasdaq held on to its top spot on the list between the June 15 and June 30 as short sellers piled on.
Between the most recent settlement dates, short sellers became more selective about the most shorted stocks traded on the Nasdaq. Those two weeks were marked by rising concerns about a possible...
Short sellers seemed to be prompted into action again in the final two weeks of last month by the overbought markets, the political and geopolitical uncertainties and the rising concerns about a...
Shares of Novavax saw a handy gain on Wednesday after the company announced updated results from its mid-stage trial for the treatment of the respiratory syncytial virus.
After showing caution last month, short sellers seemed to be prompted into action in the first two weeks of this month, judging by the moves in the most shorted stocks traded on the Nasdaq